Testing of ATM inhibitors in acute leukemia is so far largely confined to preclinical investigations but early-phase clinical trials in other cancers have been completed [36] or initiated (e.g., NCT03423628, NCT05116254, NCT05182905, NCT05396833, NCT06433219, NCT06894979). Here, ATM is linked to acute leukemia.